Modular Medical, Inc.(MODD)

Medical - Devices · San Diego, CA

$2.73+0.43 (+18.70%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T21:12:50.846Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:12:50.846Z.

Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 2.73
Unrounded diluted TTM EPS · period ending 2026-06-30: -10.06

FMP input reference: 85842aa9b6cc8ebfa961f669867d571d507c26eab2d350d24b64fb3509ac0979

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

MODD PE Ratio Metrics

PE RATIO

N/A

MODD Competitors' PE Ratio

MODD

Modular Medical, Inc.

Current

Market Cap

$22.25M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AYTU

Aytu BioPharma, Inc.

vs MODD

Market Cap

$22.00M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LONA

LeonaBio, Inc.

vs MODD

Market Cap

$22.68M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RNTX

Rein Therapeutics Inc.

vs MODD

Market Cap

$23.06M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TXMD

TherapeuticsMD, Inc.

vs MODD

Market Cap

$23.38M

PE Ratio

N/A

TTM Avg

89.23

3Y Avg

89.23

5Y Avg

89.23

NXTC

NextCure, Inc.

vs MODD

Market Cap

$20.53M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KYNB

Kyntra Bio, Inc.

vs MODD

Market Cap

$24.13M

PE Ratio

N/A

TTM Avg

2502.34

3Y Avg

2502.34

5Y Avg

2502.34

ATOS

Atossa Therapeutics, Inc.

vs MODD

Market Cap

$24.44M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NSPR

InspireMD, Inc.

vs MODD

Market Cap

$24.60M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

QNTM

Quantum BioPharma Ltd.

vs MODD

Market Cap

$19.77M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Modular Medical, Inc. (MODD)	$22.25M	N/A	N/A	N/A	N/A
Aytu BioPharma, Inc. (AYTU)vs ›	$22.00M	N/A	N/A	N/A	N/A
LeonaBio, Inc. (LONA)vs ›	$22.68M	N/A	N/A	N/A	N/A
Rein Therapeutics Inc. (RNTX)vs ›	$23.06M	N/A	N/A	N/A	N/A
TherapeuticsMD, Inc. (TXMD)vs ›	$23.38M	N/A	89.23	89.23	89.23
NextCure, Inc. (NXTC)vs ›	$20.53M	N/A	N/A	N/A	N/A
Kyntra Bio, Inc. (KYNB)vs ›	$24.13M	N/A	2502.34	2502.34	2502.34
Atossa Therapeutics, Inc. (ATOS)vs ›	$24.44M	N/A	N/A	N/A	N/A
InspireMD, Inc. (NSPR)vs ›	$24.60M	N/A	N/A	N/A	N/A
Quantum BioPharma Ltd. (QNTM)vs ›	$19.77M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$2.73

Forward EPS (Est.)

$-17.10

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

MODD PE Ratio Metrics

MODD Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics